AI tools, including CGM-linked smartphone apps, deep learning algorithms for insulin dosing, and predictive models for disease progression, customize therapies for the Indian T2D phenotype, characterized by high insulin resistance and abdominal adiposity. The gene discussed is INS; the disease is type 2 diabetes mellitus.